Impact of variants in CETP and apo AI genes on serum HDL cholesterol levels in men and women from the Polish population
- PMID: 27904507
- PMCID: PMC5108385
- DOI: 10.5114/aoms.2016.60870
Impact of variants in CETP and apo AI genes on serum HDL cholesterol levels in men and women from the Polish population
Abstract
Introduction: Polymorphisms in the cholesterol ester transfer protein (CETP) gene and apolipoprotein AI (apo AI) gene are identified as the most common genetic factors influencing high-density lipoprotein cholesterol (HDL cholesterol) levels. Low HDL cholesterol is an important risk factor for cardiovascular disease. We investigated the effect of the TaqIB polymorphism of the CETP gene and the 75G/A polymorphism of the apo AI gene on the HDL cholesterol concentration in a sample of Polish adults.
Material and methods: A total of 621 subjects, 414 women and 207 men, were included in this study. Lipid levels were measured using standard protocols, and apolipoprotein AI was determined by immunoturbidimetric assay. CETP and apo AI genotyping was performed using a restriction fragment length polymorphism based method.
Results: Significantly lower HDL cholesterol concentrations were found in B1B1 homozygotes than in carriers of the B2 allele of the TaqIB polymorphism in the CETP gene among both men and women. In GG homozygotes of the 75G/A polymorphism in the apo AI gene lower HDL cholesterol levels were observed, but the difference did not reach statistical significance. A statistically significant association of low HDL cholesterol (< 25th percentile) with CETP genotypes was found in women (p < 0.0001) and in men (p = 0.0368).
Conclusions: These data demonstrate a significant impact of the TaqIB polymorphism in the CETP gene on HDL cholesterol levels in the studied Polish population, while the effect of the 75G/A polymorphism in the apo AI gene appears not to be significant.
Keywords: apolipoprotein AI; cholesterol ester transfer protein; gene polymorphism; high-density lipoprotein cholesterol.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Associations of Cholesteryl Ester Transfer Protein TaqIB Polymorphism with the Composite Ischemic Cardiovascular Disease Risk and HDL-C Concentrations: A Meta-Analysis.Int J Environ Res Public Health. 2016 Sep 5;13(9):882. doi: 10.3390/ijerph13090882. Int J Environ Res Public Health. 2016. PMID: 27608031 Free PMC article. Review.
-
TaqIB polymorphism in the CETP gene modulates the impact of HC/LF diet on the HDL profile in healthy Chinese young adults.J Nutr Biochem. 2010 Nov;21(11):1114-9. doi: 10.1016/j.jnutbio.2009.09.009. Epub 2010 Feb 6. J Nutr Biochem. 2010. PMID: 20138746
-
Interactions between alcohol intake and the polymorphism of rs708272 on serum high-density lipoprotein cholesterol levels in the Guangxi Hei Yi Zhuang population.Alcohol. 2008 Nov;42(7):583-91. doi: 10.1016/j.alcohol.2008.08.004. Alcohol. 2008. PMID: 18835593
-
Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis.Pharmacogenomics. 2008 Jun;9(6):747-63. doi: 10.2217/14622416.9.6.747. Pharmacogenomics. 2008. PMID: 18518852 Review.
-
Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.Diabetes. 1997 Dec;46(12):2082-7. doi: 10.2337/diab.46.12.2082. Diabetes. 1997. PMID: 9392500 Clinical Trial.
Cited by
-
Alcohol Drinking, Apolipoprotein Polymorphisms and the Risk of Cardiovascular Diseases.Curr Neurovasc Res. 2021;18(1):150-161. doi: 10.2174/1567202618666210406123503. Curr Neurovasc Res. 2021. PMID: 33823779 Free PMC article. Review.
-
Effects of Obesity and Family History of Diabetes on the Association of CETP rs6499861 with HDL-C Level in Korean Populations.J Lipid Atheroscler. 2019 Sep;8(2):252-257. doi: 10.12997/jla.2019.8.2.252. Epub 2019 Sep 9. J Lipid Atheroscler. 2019. PMID: 32821715 Free PMC article.
-
Low apoA-I is associated with insulin resistance in patients with impaired glucose tolerance: a cross-sectional study.Lipids Health Dis. 2017 Apr 4;16(1):69. doi: 10.1186/s12944-017-0446-1. Lipids Health Dis. 2017. PMID: 28372564 Free PMC article.
References
-
- Libby P. Changing concepts of atherogenesis. J Intern Med. 2000;247:349–58. - PubMed
-
- Goff DC, Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49–73. - PubMed
-
- Barylski M, Toth PP, Nikolic D, Banach M, Rizzo M, Montalto G. Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality. Best Pract Res Clin Endocrinol Metab. 2014;28:453–61. - PubMed
-
- Ray KK, Cannon CP, Cairns R, Morrow DA, Ridker PM, Braunwald E. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22. Arterioscler Thromb Vasc Biol. 2009;29:424–30. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources